Analogs 38 and 39 did not inhibit any of the remaining three kinases tested. Therefore, while analogs 20 and 38 displayed appreciable activity against IRK the inhibition does not appear to be intrinsic to the scaffold as 39 was inactive against these targets. Nevertheless, it would be prudent to continue to monitor analog effects on kinases and expand the panel for future studies.